Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
Matthew S McKinney, Anne W Beaven Division of Hematologic Malignancies, Department of Medicine, Duke University Medical Center, Durham, NC, USA Abstract: Most cases of indolent non-Hodgkin lymphoma (NHL) are incurable with standard chemoimmunotherapy approaches, and patients with relapsed/refracto...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/b9627e99554348259522087327de8adb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|